Mettler-Toledo’s (NYSE:MTD) Q3 Sales Beat EstimatesPrecision measurement company Mettler-Toledo (
NYSE:MTD) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 7.9% year on year to $1.03 billion. On the other hand, next quarter’s revenue guidance of $1.08 billion was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $11.15 per share was 4.5% above analysts’ consensus estimates.
StepStone Group (NASDAQ:STEP) Delivers Strong Q3 NumbersPrivate markets investment firm StepStone Group (
NASDAQ:STEP) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 118% year on year to $454.2 million. Its non-GAAP profit of $0.54 per share was 10.6% above analysts’ consensus estimates.
NerdWallet (NASDAQ:NRDS) Reports Bullish Q3, Stock SoarsFinancial guidance platform NerdWallet (
NASDAQ:NRDS) announced better-than-expected revenue in Q3 CY2025, with sales up 12.4% year on year to $215.1 million. Its non-GAAP profit of $0.34 per share was 7.3% above analysts’ consensus estimates.
Astrana Health (NASDAQ:ASTH) Beats Q3 Sales ExpectationsHealthcare services company Astrana Health reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 99.7% year on year to $956 million. On the other hand, the company’s full-year revenue guidance of $3.14 billion at the midpoint came in 2.2% below analysts’ estimates. Its GAAP profit of $0.01 per share was 97.6% below analysts’ consensus estimates.
Affirm (NASDAQ:AFRM) Reports Upbeat Q3, Stock Jumps 12.8%Buy now, pay later company Affirm (
NASDAQ:AFRM) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 33.6% year on year to $933.3 million. Its GAAP profit of $0.23 per share was significantly above analysts’ consensus estimates.
News Corp’s (NASDAQ:NWSA) Q3: Beats On RevenueGlobal media and publishing company News Corp (
NASDAQ:NWSA) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.3% year on year to $2.14 billion. Its GAAP profit of $0.20 per share was 9.4% above analysts’ consensus estimates.
Universal Display (NASDAQ:OLED) Misses Q3 Analysts’ Revenue Estimates, Stock Drops 14.4%OLED provider Universal Display (
NASDAQ:OLED) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 13.6% year on year to $139.6 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $675 million at the midpoint. Its GAAP profit of $0.92 per share was 21.6% below analysts’ consensus estimates.
RB Global (NYSE:RBA) Surprises With Strong Q3Commercial asset marketplace RB Global (
NYSE:RBA) announced better-than-expected revenue in Q3 CY2025, with sales up 11.3% year on year to $1.09 billion. Its non-GAAP profit of $0.93 per share was 17.3% above analysts’ consensus estimates.
Five9 (NASDAQ:FIVN) Reports Q3 In Line With ExpectationsCloud contact center software provider Five9 (
NASDAQ:FIVN) met Wall Streets revenue expectations in Q3 CY2025, with sales up 8.2% year on year to $285.8 million. On the other hand, next quarter’s revenue guidance of $297.7 million was less impressive, coming in 0.8% below analysts’ estimates. Its non-GAAP profit of $0.78 per share was 6.5% above analysts’ consensus estimates.
WillScot Mobile Mini (NASDAQ:WSC) Misses Q3 Revenue Estimates, Stock DropsTemporary space provider WillScot (
NASDAQ:WSC) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 5.8% year on year to $566.8 million. Next quarter’s revenue guidance of $545 million underwhelmed, coming in 6.6% below analysts’ estimates. Its non-GAAP profit of $0.30 per share was 3.9% above analysts’ consensus estimates.
Doximity’s (NYSE:DOCS) Q3: Beats On Revenue But Stock DropsMedical professional network Doximity (
NYSE:DOCS) announced better-than-expected revenue in Q3 CY2025, with sales up 23.2% year on year to $168.5 million. The company expects next quarter’s revenue to be around $180.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.45 per share was 18.7% above analysts’ consensus estimates.
Blink Charging (NASDAQ:BLNK) Reports Sales Below Analyst Estimates In Q3 EarningsEV charging infrastructure provider Blink Charging (
NASDAQ:BLNK) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 7.3% year on year to $27.03 million. Its non-GAAP loss of $0.10 per share was in line with analysts’ consensus estimates.
Sunrun’s (NASDAQ:RUN) Q3 Sales Top Estimates But Stock DropsResidential solar energy company Sunrun (
NASDAQ:RUN) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 34.9% year on year to $724.6 million. Its GAAP profit of $0.06 per share was 58.2% below analysts’ consensus estimates.
PAR Technology’s (NYSE:PAR) Q3: Strong Sales, Stock SoarsRestaurant technology provider PAR Technology (
NYSE:PAR) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 23.2% year on year to $119.2 million. Its non-GAAP profit of $0.06 per share was significantly above analysts’ consensus estimates.
Funko (NASDAQ:FNKO) Reports Sales Below Analyst Estimates In Q3 Earnings, But Stock Soars 15.9%Pop culture collectibles manufacturer Funko (
NASDAQ:FNKO) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 14.3% year on year to $250.9 million. Its non-GAAP profit of $0.06 per share was significantly above analysts’ consensus estimates.
Mueller Water Products’s (NYSE:MWA) Q3 Sales Beat EstimatesWater infrastructure products manufacturer Mueller Water Products beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 9.4% year on year to $380.8 million. On the other hand, the company’s full-year revenue guidance of $1.46 billion at the midpoint came in 0.6% below analysts’ estimates. Its non-GAAP profit of $0.38 per share was 12.3% above analysts’ consensus estimates.
Dropbox’s (NASDAQ:DBX) Q3 Sales Top Estimates But Customer Growth Slows DownCloud storage company Dropbox (
NASDAQ:DBX) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on year at $634.4 million. Its non-GAAP profit of $0.74 per share was 14.1% above analysts’ consensus estimates.
Flowers Foods (NYSE:FLO) Reports Q3 In Line With ExpectationsPackaged bakery food company Flower Foods (
NYSE:FLO) met Wall Streets revenue expectations in Q3 CY2025, with sales up 3% year on year to $1.23 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $5.28 billion at the midpoint. Its non-GAAP profit of $0.23 per share was in line with analysts’ consensus estimates.
Karat Packaging (NASDAQ:KRT) Posts Q3 Sales In Line With EstimatesFoodservice packaging supplier Karat Packaging (
NASDAQ:KRT) met Wall Streets revenue expectations in Q3 CY2025, with sales up 10.4% year on year to $124.5 million. The company expects next quarter’s revenue to be around $113.8 million, coming in 1.7% above analysts’ estimates. Its non-GAAP profit of $0.37 per share was 5.1% below analysts’ consensus estimates.
Palomar Holdings (NASDAQ:PLMR) Reports Strong Q3, Stock SoarsSpecialty insurance provider Palomar Holdings (
NASDAQ:PLMR) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 64.8% year on year to $244.7 million. Its non-GAAP profit of $2.01 per share was 24.8% above analysts’ consensus estimates.
Monster (NASDAQ:MNST) Delivers Impressive Q3Energy drink company Monster Beverage (
NASDAQ:MNST) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 16.8% year on year to $2.20 billion. Its non-GAAP profit of $0.56 per share was 17.5% above analysts’ consensus estimates.
Evolent Health (NYSE:EVH) Beats Q3 Sales Expectations, Stock Jumps 14.8%Healthcare solutions company Evolent Health (
NYSE:EVH) beat Wall Street’s revenue expectations in Q3 CY2025, but sales fell by 22.8% year on year to $479.5 million. On the other hand, next quarter’s revenue guidance of $467 million was less impressive, coming in 1.2% below analysts’ estimates. Its non-GAAP profit of $0.05 per share was 52.5% below analysts’ consensus estimates.
eXp World (NASDAQ:EXPI) Reports Bullish Q3Real estate technology company eXp World (
NASDAQ:EXPI) announced better-than-expected revenue in Q3 CY2025, with sales up 6.9% year on year to $1.32 billion. Its GAAP profit of $0.02 per share was in line with analysts’ consensus estimates.
Clarus (NASDAQ:CLAR) Exceeds Q3 ExpectationsOutdoor lifestyle and equipment company Clarus (
NASDAQ:CLAR) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 3.3% year on year to $69.35 million. Its non-GAAP profit of $0.05 per share was in line with analysts’ consensus estimates.
Topgolf Callaway’s (NYSE:MODG) Q3 Sales Beat Estimates, Stock SoarsGolf entertainment and gear company Topgolf Callaway (
NYSE:MODG) reported Q3 CY2025 results exceeding the market’s revenue expectations, but sales fell by 7.8% year on year to $934 million. The company expects next quarter’s revenue to be around $783 million, close to analysts’ estimates. Its non-GAAP loss of $0.05 per share was 76.9% above analysts’ consensus estimates.
Globalstar (NASDAQ:GSAT) Reports Upbeat Q3Satellite communications provider Globalstar (
NASDAQ:GSAT) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 2.1% year on year to $73.85 million. The company’s full-year revenue guidance of $272.5 million at the midpoint came in 2.9% above analysts’ estimates. Its GAAP loss of $0.01 per share was $0.02 above analysts’ consensus estimates.
F&G Annuities & Life (NYSE:FG) Reports Strong Q3Insurance solutions provider F&G Annuities & Life (
NYSE:FG) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 16.5% year on year to $1.69 billion. Its non-GAAP profit of $1.22 per share was 25.4% above analysts’ consensus estimates.
Amphastar Pharmaceuticals (NASDAQ:AMPH) Delivers Strong Q3 NumbersPharmaceutical company Amphastar Pharmaceuticals (NASDAQAMPH) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales were flat year on year at $191.8 million. Its non-GAAP profit of $0.93 per share was 12.7% above analysts’ consensus estimates.
Globus Medical’s (NYSE:GMED) Q3: Strong Sales, Stock Jumps 19.2%Medical device company Globus Medical (
NYSE:GMED) announced better-than-expected revenue in Q3 CY2025, with sales up 22.9% year on year to $769 million. The company’s full-year revenue guidance of $2.88 billion at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $1.18 per share was 53.4% above analysts’ consensus estimates.
Brookdale (NYSE:BKD) Misses Q3 Revenue EstimatesSenior living provider Brookdale Senior Living (
NYSE:BKD) fell short of the markets revenue expectations in Q3 CY2025 as sales rose 3.7% year on year to $813.2 million. Its GAAP loss of $0.48 per share was significantly below analysts’ consensus estimates.
QuinStreet’s (NASDAQ:QNST) Q3 Sales Beat Estimates, Stock Jumps 11.2%Performance marketing company QuinStreet (
NASDAQ:QNST) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 2.4% year on year to $285.9 million. The company expects next quarter’s revenue to be around $275 million, close to analysts’ estimates. Its non-GAAP profit of $0.22 per share was in line with analysts’ consensus estimates.
Nelnet (NYSE:NNI) Reports Upbeat Q3Education finance company Nelnet (
NYSE:NNI) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 47.6% year on year to $427.8 million. Its GAAP profit of $2.94 per share was 93.4% above analysts’ consensus estimates.
Alamo’s (NYSE:ALG) Q3 Sales Top EstimatesSpecialized equipment manufacturer for infrastructure and vegetation management Alamo Group (
NYSE:ALG) announced better-than-expected revenue in Q3 CY2025, with sales up 4.7% year on year to $420 million. Its non-GAAP profit of $2.34 per share was 11.3% below analysts’ consensus estimates.
Natera (NASDAQ:NTRA) Delivers Impressive Q3Genetic testing company Natera (
NASDAQ:NTRA). reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 34.7% year on year to $592.2 million. The company’s full-year revenue guidance of $2.22 billion at the midpoint came in 6.1% above analysts’ estimates. Its GAAP loss of $0.64 per share was 74.5% below analysts’ consensus estimates.
Solventum’s (NYSE:SOLV) Q3: Beats On RevenueHealthcare solutions provider Solventum (
NYSE:SOLV) reported Q3 CY2025 results topping the market’s revenue expectations, but sales were flat year on year at $2.10 billion. Its non-GAAP profit of $1.50 per share was 4.7% above analysts’ consensus estimates.
DraftKings (NASDAQ:DKNG) Reports Sales Below Analyst Estimates In Q3 EarningsFantasy sports and betting company DraftKings (
NASDAQ:DKNG) fell short of the markets revenue expectations in Q3 CY2025 as sales rose 4.4% year on year to $1.14 billion. The company’s full-year revenue guidance of $6 billion at the midpoint came in 3.1% below analysts’ estimates. Its non-GAAP loss of $0.26 per share was in line with analysts’ consensus estimates.
Alarm.com (NASDAQ:ALRM) Posts Better-Than-Expected Sales In Q3Smart property technology provider Alarm.com (
NASDAQ:ALRM) announced better-than-expected revenue in Q3 CY2025, with sales up 6.6% year on year to $256.4 million. Its non-GAAP profit of $0.76 per share was 24.3% above analysts’ consensus estimates.
Microchip Technology (NASDAQ:MCHP) Reports Q3 In Line With Expectations But Stock DropsAnalog chipmaker Microchip Technology (
NASDAQ:MCHP) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 2% year on year to $1.14 billion. On the other hand, next quarter’s revenue guidance of $1.13 billion was less impressive, coming in 4.3% below analysts’ estimates. Its non-GAAP profit of $0.35 per share was 4.9% above analysts’ consensus estimates.
BlackLine (NASDAQ:BL) Posts Q3 Sales In Line With Estimates But Customer Growth Slows DownFinancial automation software company BlackLine (
NASDAQ:BL) met Wall Streets revenue expectations in Q3 CY2025, with sales up 7.5% year on year to $178.3 million. The company expects next quarter’s revenue to be around $183 million, close to analysts’ estimates. Its non-GAAP profit of $0.51 per share was in line with analysts’ consensus estimates.
Nature's Sunshine’s (NASDAQ:NATR) Q3: Strong SalesWellness products company Nature’s Sunshine (
NASDAQ:NATR) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12% year on year to $128.3 million. The company’s full-year revenue guidance of $478 million at the midpoint came in 2.3% above analysts’ estimates. Its non-GAAP profit of $0.36 per share was significantly above analysts’ consensus estimates.
Cable One (NYSE:CABO) Misses Q3 Revenue EstimatesInternet, cable TV, and phone provider Cable One (
NYSE:CABO) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 4.5% year on year to $376 million. Its GAAP profit of $14.52 per share was 94.5% above analysts’ consensus estimates.
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1%Biotech company 10x Genomics (
NASDAQ:TXG) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 1.7% year on year to $149 million. On top of that, next quarter’s revenue guidance ($156 million at the midpoint) was surprisingly good and 3.5% above what analysts were expecting. Its GAAP loss of $0.22 per share was 22.3% above analysts’ consensus estimates.
H&R Block’s (NYSE:HRB) Q3: Beats On RevenueTax preparation company H&R Block (
NYSE:HRB) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 5% year on year to $203.6 million. The company expects the full year’s revenue to be around $3.89 billion, close to analysts’ estimates. Its non-GAAP loss of $1.20 per share was 11.3% above analysts’ consensus estimates.
Main Street Capital (NYSE:MAIN) Reports Q3 In Line With ExpectationsBusiness development company Main Street Capital (
NYSE:MAIN) met Wall Streets revenue expectations in Q3 CY2025, with sales up 2.2% year on year to $139.8 million. Its non-GAAP profit of $1.03 per share was 5.2% above analysts’ consensus estimates.
AMN Healthcare Services’s (NYSE:AMN) Q3 Sales Top Estimates, Stock SoarsHealthcare staffing company AMN Healthcare Services (
NYSE:AMN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 7.7% year on year to $634.5 million. On top of that, next quarter’s revenue guidance ($722.5 million at the midpoint) was surprisingly good and 16.4% above what analysts were expecting. Its non-GAAP profit of $0.39 per share was 95.2% above analysts’ consensus estimates.
Figs’s (NYSE:FIGS) Q3: Strong Sales, Stock Jumps 16.2%Healthcare apparel company Figs (
NYSE:FIGS) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 8.2% year on year to $151.7 million. Its non-GAAP profit of $0.05 per share was significantly above analysts’ consensus estimates.
Xponential Fitness’s (NYSE:XPOF) Q3 Sales Beat Estimates, Stock Jumps 13.5%Boutique fitness studio franchisor Xponential Fitness (
NYSE:XPOF) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 2.1% year on year to $78.82 million. The company expects the full year’s revenue to be around $305 million, close to analysts’ estimates. Its non-GAAP profit of $0.34 per share was significantly above analysts’ consensus estimates.
Alta (NYSE:ALTG) Misses Q3 Revenue Estimates, Stock DropsEquipment distribution company Alta Equipment Group (
NYSE:ALTG) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 5.8% year on year to $422.6 million. Its non-GAAP loss of $0.35 per share was significantly below analysts’ consensus estimates.
Opendoor (NASDAQ:OPEN) Beats Q3 Sales Expectations But Stock DropsTechnology real estate company Opendoor (
NASDAQ:OPEN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 33.6% year on year to $915 million. Its GAAP loss of $0.12 per share was 68.5% below analysts’ consensus estimates.
HCI Group (NYSE:HCI) Reports Sales Below Analyst Estimates In Q3 EarningsInsurance and technology company HCI Group (
NYSE:HCI) missed Wall Street’s revenue expectations in Q3 CY2025, but sales rose 23.4% year on year to $216.4 million. Its GAAP profit of $4.90 per share was significantly above analysts’ consensus estimates.
Pangaea (NASDAQ:PANL) Surprises With Strong Q3Pangaea Logistics (
NASDAQ:PANL) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 10.2% year on year to $168.7 million. Its non-GAAP profit of $0.17 per share was significantly above analysts’ consensus estimates.
The ONE Group (NASDAQ:STKS) Misses Q3 Sales ExpectationsUpscale restaurant company The One Group Hospitality (
NASDAQ:STKS) missed Wall Street’s revenue expectations in Q3 CY2025, with sales falling 7.1% year on year to $180.2 million. The company’s full-year revenue guidance of $822.5 million at the midpoint came in 1.5% below analysts’ estimates. Its GAAP loss of $2.75 per share was significantly below analysts’ consensus estimates.
Fidelity National Financial (NYSE:FNF) Beats Expectations in Strong Q3Title insurance company Fidelity National Financial (
NYSE:FNF) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 11.9% year on year to $4.03 billion. Its non-GAAP profit of $1.63 per share was 14.5% above analysts’ consensus estimates.
E.W. Scripps (NASDAQ:SSP) Posts Q3 Sales In Line With EstimatesMedia, broadcasting, and digital services company E.W. Scripps (
NASDAQ:SSP) met Wall Streets revenue expectations in Q3 CY2025, but sales fell by 18.6% year on year to $525.9 million. Its GAAP loss of $0.55 per share was 70.8% below analysts’ consensus estimates.
Arlo Technologies’s (NYSE:ARLO) Q3 Sales Beat EstimatesSmart security company Arlo (
NYSE:ARLO) announced better-than-expected revenue in Q3 CY2025, with sales up 1.4% year on year to $139.5 million. The company expects next quarter’s revenue to be around $136 million, close to analysts’ estimates. Its non-GAAP profit of $0.16 per share was 8% above analysts’ consensus estimates.
EVERTEC (NYSE:EVTC) Surprises With Q3 SalesPayment processing company EVERTEC (
NYSE:EVTC) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 7.9% year on year to $228.6 million. The company’s full-year revenue guidance of $924 million at the midpoint came in 2.1% above analysts’ estimates. Its non-GAAP profit of $0.92 per share was 3.5% above analysts’ consensus estimates.
Sweetgreen (NYSE:SG) Misses Q3 Revenue Estimates, Stock DropsCasual salad chain Sweetgreen (
NYSE:SG) missed Wall Street’s revenue expectations in Q3 CY2025, with sales flat year on year at $172.4 million. The company’s full-year revenue guidance of $685 million at the midpoint came in 2.5% below analysts’ estimates. Its GAAP loss of $0.31 per share was 76.2% below analysts’ consensus estimates.
HA Sustainable Infrastructure Capital (NYSE:HASI) Reports Strong Q3Climate investment firm HA Sustainable Infrastructure Capital (
NYSE:HASI) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 12.2% year on year to $103.1 million. Its non-GAAP profit of $0.80 per share was 16.1% above analysts’ consensus estimates.
BILL (NYSE:BILL) Posts Better-Than-Expected Sales In Q3, Stock SoarsFinancial automation platform BILL (
NYSE:BILL) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 10.4% year on year to $395.7 million. The company expects next quarter’s revenue to be around $399.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.61 per share was 20.5% above analysts’ consensus estimates.
Take-Two (NASDAQ:TTWO) Surprises With Q3 Sales But Stock DropsVideo game publisher Take Two (
NASDAQ:TTWO) announced better-than-expected revenue in Q3 CY2025, with sales up 20.3% year on year to $1.77 billion. On top of that, next quarter’s revenue guidance ($1.60 billion at the midpoint) was surprisingly good and 6.7% above what analysts were expecting. Its GAAP loss of $0.73 per share was 17.1% below analysts’ consensus estimates.
Artivion’s (NYSE:AORT) Q3 Sales Top EstimatesMedical device company Artivion (
NYSE:AORT) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 18.4% year on year to $113.4 million. The company’s full-year revenue guidance of $442 million at the midpoint came in 0.9% above analysts’ estimates. Its non-GAAP profit of $0.16 per share was in line with analysts’ consensus estimates.
Trupanion (NASDAQ:TRUP) Exceeds Q3 ExpectationsPet insurance provider Trupanion (
NASDAQ:TRUP) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 12.1% year on year to $366.9 million. Its GAAP profit of $0.13 per share was 90.3% above analysts’ consensus estimates.
AerSale (NASDAQ:ASLE) Misses Q3 Sales ExpectationsAerospace and defense company AerSale (
NASDAQ:ASLE) fell short of the markets revenue expectations in Q3 CY2025, with sales falling 13.9% year on year to $71.19 million. Its non-GAAP profit of $0.04 per share was 77.1% below analysts’ consensus estimates.
Genpact (NYSE:G) Posts Better-Than-Expected Sales In Q3Business transformation services company Genpact (
NYSE:G) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 6.6% year on year to $1.29 billion. Guidance for next quarter’s revenue was better than expected at $1.30 billion at the midpoint, 1.2% above analysts’ estimates. Its non-GAAP profit of $0.97 per share was 8% above analysts’ consensus estimates.
Yelp’s (NYSE:YELP) Q3: Beats On RevenueLocal business platform Yelp (
NYSE:YELP) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 4.4% year on year to $376 million. The company expects the full year’s revenue to be around $1.46 billion, close to analysts’ estimates. Its GAAP profit of $0.61 per share was 16.1% above analysts’ consensus estimates.
Expedia’s (NASDAQ:EXPE) Q3: Beats On RevenueOnline travel agency Expedia (
NASDAQ:EXPE) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 8.7% year on year to $4.41 billion. On top of that, next quarter’s revenue guidance ($3.41 billion at the midpoint) was surprisingly good and 4.2% above what analysts were expecting. Its non-GAAP profit of $7.57 per share was 9% above analysts’ consensus estimates.
Tandem Diabetes (NASDAQ:TNDM) Beats Expectations in Strong Q3, Stock Jumps 17.5%Diabetes technology company Tandem Diabetes Care (
NASDAQ:TNDM) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 2.2% year on year to $249.3 million. Its GAAP loss of $0.31 per share was 3.6% above analysts’ consensus estimates.
LeMaitre (NASDAQ:LMAT) Reports Sales Below Analyst Estimates In Q3 EarningsMedical device company LeMaitre Vascular (
NASDAQ:LMAT) fell short of the markets revenue expectations in Q3 CY2025, but sales rose 11.4% year on year to $61.05 million. Next quarter’s revenue guidance of $62.8 million underwhelmed, coming in 2.9% below analysts’ estimates. Its GAAP profit of $0.75 per share was 31.5% above analysts’ consensus estimates.
The Trade Desk (NASDAQ:TTD) Surprises With Q3 Sales But Stock DropsDigital advertising platform The Trade Desk (
NASDAQ:TTD) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 17.7% year on year to $739.4 million. Guidance for next quarter’s revenue was better than expected at $840 million at the midpoint, 1% above analysts’ estimates. Its non-GAAP profit of $0.45 per share was in line with analysts’ consensus estimates.
nLIGHT (NASDAQ:LASR) Delivers Strong Q3 Numbers, Stock Jumps 15.9%Laser company nLIGHT (
NASDAQ:LASR) reported Q3 CY2025 results beating Wall Street’s revenue expectations, with sales up 18.9% year on year to $66.74 million. On top of that, next quarter’s revenue guidance ($75 million at the midpoint) was surprisingly good and 22.8% above what analysts were expecting. Its non-GAAP profit of $0.08 per share was significantly above analysts’ consensus estimates.
JFrog (NASDAQ:FROG) Beats Expectations in Strong Q3, Stock Jumps 22.7%Software supply chain platform JFrog (
NASDAQ:FROG) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 25.5% year on year to $136.9 million. On top of that, next quarter’s revenue guidance ($137.5 million at the midpoint) was surprisingly good and 4.8% above what analysts were expecting. Its non-GAAP profit of $0.22 per share was 34.4% above analysts’ consensus estimates.
ePlus (NASDAQ:PLUS) Reports Strong Q3, Stock SoarsIT solutions provider ePlus (
NASDAQ:PLUS) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 18.2% year on year to $608.8 million. Its non-GAAP profit of $1.53 per share was 61.9% above analysts’ consensus estimates.
ICU Medical’s (NASDAQ:ICUI) Q3: Strong SalesMedical device company ICU Medical (
NASDAQ:ICUI) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 8.9% year on year to $537 million. Its non-GAAP profit of $2.03 per share was 41.6% above analysts’ consensus estimates.
CarGurus (NASDAQ:CARG) Surprises With Q3 Sales, Stock SoarsOnline auto marketplace CarGurus (
NASDAQ:CARG) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 3.2% year on year to $238.7 million. Guidance for next quarter’s revenue was better than expected at $238.5 million at the midpoint, 0.6% above analysts’ estimates. Its non-GAAP profit of $0.57 per share was 3.7% above analysts’ consensus estimates.
Kura Sushi’s (NASDAQ:KRUS) Q3 Sales Beat EstimatesSushi restaurant chain Kura Sushi (
NASDAQ:KRUS) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 20.4% year on year to $79.45 million. On the other hand, the company’s full-year revenue guidance of $332 million at the midpoint came in 1.9% below analysts’ estimates. Its non-GAAP profit of $0.20 per share was 63.4% above analysts’ consensus estimates.
